Valsartan Starting Dose
For adult hypertension with normal renal function, start valsartan at 80 mg once daily, with 160 mg once daily as an alternative higher starting dose for patients requiring greater blood pressure reduction. 1
Dosing by Indication
Hypertension (Adult)
- Standard starting dose: 80 mg once daily 1
- Alternative starting dose: 160 mg once daily for patients requiring greater blood pressure reductions 1
- Dose range: 80-320 mg daily 1
- Maximum antihypertensive effect achieved within 4 weeks 1
- If additional blood pressure lowering needed beyond starting dose, either increase to maximum 320 mg daily OR add a diuretic (adding diuretic more effective than dose increases beyond 80 mg) 1
Heart Failure with Reduced Ejection Fraction
- Starting dose: 40 mg twice daily 1
- Uptitrate to 80 mg twice daily, then 160 mg twice daily as tolerated 1
- Target dose: 160 mg twice daily (320 mg total daily) 2, 3
- Consider reducing concomitant diuretic dose when initiating 1
Post-Myocardial Infarction
- Starting dose: 20 mg twice daily (can initiate as early as 12 hours post-MI) 4, 1
- Uptitrate within 7 days to 40 mg twice daily 1
- Target dose: 160 mg twice daily 4, 1
- Reduce dose if symptomatic hypotension or renal dysfunction occurs 1
Key Dosing Principles
The evidence strongly supports titrating to target doses, not settling for low doses. Multiple guidelines emphasize that target doses from clinical trials provide superior outcomes compared to lower doses 2, 5. The 2020 ACC/AHA performance measures specifically recommend achieving at least 50% of target dose (160 mg total daily for valsartan in heart failure) 2.
Common Pitfall to Avoid
Many clinicians use hypertension doses (40-80 mg daily) when treating heart failure, but the target dose for heart failure is 160 mg twice daily (320 mg total daily) - substantially higher than typical hypertension dosing 2, 5. This represents a critical knowledge gap, as the dose-response relationship shows greater benefits at higher doses 5.
Contraindications and Cautions
- Avoid in: Hypotension, renal failure, hyperkalemia 4
- Do not combine with ACE inhibitors or other ARBs simultaneously 6
- Monitor blood pressure, renal function, and potassium during uptitration 1
Uptitration Strategy
The most dramatic blood pressure decrease occurs with the initial starting dose; subsequent dose increases produce comparatively modest additional blood pressure reductions 5. This means uptitration is generally well-tolerated and should be pursued aggressively to reach target doses within 2-4 weeks for hypertension 1 and up to several weeks for heart failure 2.
If patients experience asymptomatic hypotension or mild worsening of renal function during uptitration, address these with supportive measures rather than immediately reducing the dose, as these changes often reflect hemodynamic adjustments rather than true organ injury 5, 7.